Cargando…
RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy
Cervical cancer is one of the most common cancers in women worldwide, being high-risk group the HPV infected, the leading etiological factor. The raf kinase inhibitory protein (RKIP) has been associated with tumor progression and metastasis in several human neoplasms, however its role on cervical ca...
Autores principales: | Martinho, Olga, Pinto, Filipe, Granja, Sara, Miranda-Gonçalves, Vera, Moreira, Marise A. R., Ribeiro, Luis F. J., di Loreto, Celso, Rosner, Marsha R., Longatto-Filho, Adhemar, Reis, Rui Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602518/ https://www.ncbi.nlm.nih.gov/pubmed/23527098 http://dx.doi.org/10.1371/journal.pone.0059104 |
Ejemplares similares
-
Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
por: Martinho, Olga, et al.
Publicado: (2012) -
Harnessing RKIP to Combat Heart Disease and Cancer
por: Lorenz, Kristina, et al.
Publicado: (2022) -
RKIP Suppresses Breast Cancer Metastasis to the Bone by Regulating Stroma-Associated Genes
por: Bevilacqua, Elena, et al.
Publicado: (2012) -
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
por: Longatto-Filho, Adhemar, et al.
Publicado: (2009) -
HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
por: Martinho, Olga, et al.
Publicado: (2017)